Got cancer? ♡bamaCare!!! has you covered! Just not as well covered as you used to be:
People with Obamacare coverage who take medications for cancer, HIV, multiple sclerosis, and other chronic diseases might pay more out of pocket next year. A greater share of insurance plans sold in the healthcare.gov marketplace will require consumers to pay 30 percent or more of the cost of specialty drugs, according to a new analysis from consultant Avalere Health.
“Specialty drugs” is an oblique way of saying “the drugs which people with the worst things will need most badly.”
Let’s continue:
Avalere looked at how much cost sharing was required for drugs insurers considered “specialty” medicines. There’s no consistent definition of specialty drugs; the term generally refers to medicine used to treat severe or rare illnesses. The doses can cost thousands of dollars a month. Asking patients to pay 30 percent of that can mean some people skip doses they can’t afford.
Yet the share of silver plans—the most popular tier of Obamacare coverage—that required that level of cost sharing jumped to 41 percent, from 27 percent last year, according to Avalere. The analysis included plans on the federal healthcare.gov marketplace and state exchanges in New York and California; other state-based exchanges were not included.
Blue state voters getting crushed under the weight of ♡bamaCare!!!? Seems like an opportunity to me.
The Democrats never hesitated to pull at the heart strings to pass this monstrosity. How about the GOP do the same, using ads with real-life HIV and cancer victims losing everything they have to pay for their once-covered meds?
Join the conversation as a VIP Member